Discover
DFTX
Definium Therapeutics, Inc.
43.40
2 x 33.45
2 x 56.46
bid
ask
-
3.64
7.74%
2 @ 06:12 AM
43.27 -0.13 (0.30%)
| Ytd | 224.12% | |
| 1y | 549.70% |
43.32
day range
47.20
6.66
52 week range
49.20
| Open | 46.83 | Prev Close | 47.04 | Low | 43.32 | High | 47.20 | Mkt Cap | 5.76B |
| Vol | 3.11M | Avg Vol | 2.82M | EPS | -2.50 | P/E | N/A | Forward P/E | -30.89 |
| Beta | 2.38 | Short Ratio | 5.00 | Inst. Own | 65.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 25.89 | 200-d Avg | 17.62 | 1yr Est | 56.00 |
| Income Statement | |||
| Operating Expenses | 59.22M | ||
| Research and Development Expense | 41.48M | ||
| Selling, General and Administrative Expense | 17.74M | ||
| Operating Income | -59.22M | ||
| Interest Expense | 1.25M | ||
| Net Income | -77.10M | ||
| Net Income Common Stock | -77.10M | ||
| Net Income Common Stock (USD) | -77.10M | ||
| Consolidated Income | -77.10M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -75.85M | ||
| Earning Before Interest & Taxes (USD) | -75.85M | ||
| Weighted Average Shares | 108.79M | ||
| Weighted Average Shares Diluted | 108.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 262.52M | ||
| Cash and Equivalents (USD) | 262.52M | ||
| Investments | 110.90M | ||
| Investments Current | 110.90M | ||
| Current Assets | 380.56M | ||
| Total Assets | 401.29M | ||
| Total Debt | 40.77M | ||
| Current Liabilities | 81.11M | ||
| Debt Non-Current | 40.77M | ||
| Total Liabilities | 122.44M | ||
| Accumulated Retained Earnings (Deficit) | -659.77M | ||
| Accumulated Other Comprehensive Income | 824.00K | ||
| Shareholders Equity | 278.85M | ||
| Shareholders Equity (USD) | 278.85M | ||
| Assets Non-Current | 20.73M | ||
| Total Debt (USD) | 40.77M | ||
| Goodwill and Intangible Assets | 19.92M | ||
| Liabilities Non-Current | 41.33M | ||
| Trade and Non-Trade Payables | 7.13M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 5.31M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.68M | ||
| Issuance (Purchase) of Equity Shares | 1.47M | ||
| Net Cash Flow from Investing | 42.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.00M | ||
| Net Cash Flow from Operations | -42.63M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 7.13M | ||